<collection><source>PMC</source><date>20201214</date><key>pmc.key</key><document><id>29058</id><infon key="license">NO-CC CODE</infon><passage><infon key="article-id_doi">10.1186/1471-2091-1-2</infon><infon key="article-id_pmc">29058</infon><infon key="article-id_pmid">11001589</infon><infon key="article-id_publisher-id">1471-2091-1-2</infon><infon key="fpage">2</infon><infon key="journal-title">BMC Biochemistry</infon><infon key="lpage">2</infon><infon key="name_0">surname:Brown;given-names:Neil G</infon><infon key="name_1">surname:Nick Morrice;given-names:D</infon><infon key="name_2">surname:Beaud;given-names:Georges</infon><infon key="name_3">surname:Hardie;given-names:Grahame</infon><infon key="name_4">surname:Leader;given-names:David P</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">1</infon><infon key="year">2000</infon><offset>0</offset><text>Identification of sites phosphorylated by the vaccinia virus B1R kinase in viral protein H5R</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>93</offset><text>What is the background on this?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>104</offset><text>Serine/threonine protein kinase, specifically the vaccinia virus gene B1R, is responsible for phosphorylating ribosomal proteins S2 and H5R in vitro. However, the specificity of these proteins' substrates and the sites of phosphatation are not known. The first work to address these questions is described here (It is possible that many other organisms have developed this knowledge earlier).</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>508</offset><text>What are the outcomes?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>516</offset><text>The B1R protein H5R was phosphorylated by the B-1 receptor in vitro and then separated by HPLC. The N-terminal sequence of one radioactively labeled phosphate was found to correspond to residues 81-87 of the protein, with Thr-84 and Moreover, both 83 and 85 were pythonically tagged to a specific alpha gene, while the extent of peptide synthesis was significantly reduced by substituting TH-131 with an Ala.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1071</offset><text>Remarkable conclusions</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1083</offset><text>The first phosphorylation site for the vaccinia virus B1R protein kinase has been identified, providing further insight into the enzyme's substrate-specificity in contrast to other known protein Kinases. However, it is unknown whether the same site is purged in vivo.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1383</offset><text>Vaccinia virus (VV) has been isolated from the human genome and has been shown to cause various types of infectious diseases, including measles (MMR) and rubella (RT). However, this virus is also present in the human blood. The only way to identify VV-positive individuals is to carry the virus. However, the virus does not have an immune system and it cannot be isolated from the human body.

The current study aims to identify the VV-positive individuals in the blood and in humans. Moreover, the aim is to determine whether VV can be isolated from the blood of individuals with known viral infections.

Materials and Methods:

We sequenced the genomes of 16 VV-negative individuals (n = 5) and</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1394</offset><text>Vaccinia virus, which is a large DNA virus that replicates in virosomes, has two protein kinases encoded by them, the products of the B1R and F10L genes. The F11L enase is essential for virion morphosis, and it is highly expressed in viral viruses. However, mutations that map to the "B1"R gene do not seem to have broader substrate specificity. This fact also suggests that three proteins involved in infection are non-phosphorylated during infection, butycytocytos</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2581</offset><text>The B1R kinase's phosphorylation in vitro does not necessarily mean that it is responsible for their physiology during viral infection. However, one possible evidence suggests that the B1,B1K phosphatases act as a mediator for pyrosegine synthesis in vivo by reducing the proportion of underphosopholipided H5R at specific temperatures.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3401</offset><text>Despite being found in virosomes, some highly phosphorylated forms of the H5R protein are believed to play multiple roles in viral development.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>4624</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>4632</offset><text>Vaccinia virus protein H5R isolated from infected HeLa cells was labelled in vitro with [&#947;-32P]ATP by recombinant B1R protein kinase, all as described in Experimental. The products of the reaction were digested with V8 protease and then passed through a SEP-PAK cartridge to remove the majority of the unreacted [&#947;-32P]ATP. The radioactive V8 peptides recovered from the cartridge were then applied to a reverse-phase HPLC column and eluted with a gradient of acetonitrile. This removed the residual [&#947;-32P]ATP, and the majority of the radioactivity associated with peptides eluted as a doublet at 20-30% acetonitrile (designated 3 in Fig. 1a), which was collected, concentrated by centrifugal evaporation, redissolved and applied to a microbore HPLC column to resolve the peptides further. A first run using a 15-25% gradient of acetonitrile in 0.1% trifluoroacetic acid revealed that this preparation of the radioactive doublet contained perhaps a dozen peptides (Fig. 1b). As these were incompletely resolved, two regions of the gradient containing the most radioactive peaks (designated in the figure as I and II, containing gradient fractions 30-33 and 35-36, respectively) were collected and reapplied in turn to the microbore column, but this time the gradient for elution comprised 0-50% acetonitrile in 20 mM NaCl without trifluoroacetic acid. Insufficient radioactivity was recovered from the peaks resolved in fraction I for sequence analysis. Fraction II yielded more radioactive peptides, separated from adjacent peptides and partly resolved from each other (peaks 28 and 29 in Fig 1c). </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>6245</offset><text>The two peaks, 28 and 29, from the microbore HPLC separation of fraction II (Fig. 1c) were separately subjected to sequence analysis using an Applied Biosystems gas phase sequencer, and the radioactivity of the PTH derivative at each cycle of Edman degradation was determined by scintillation spectrometry. The results of thirteen cycles of automatic Edman degradation on peak 29 are shown in Fig 2. The first seven residues of the peptide were identified as YHQTTEK, which correspond exactly to residues 81-87 of H5R and do not occur elsewhere in the protein. (The preceding residue 80 in the protein is glutamic acid, consistent with the substrate specificity of V8 protease.) The 32P was released from the peptide predominantly at cycles 4, 5 and 6. As there is always carry-over from one cycle to the next, we can conclude that both residues Thr-84 and Thr-85 of H5R are phosphorylated by the vaccinia virus B1R protein kinase. Analysis of fraction 28 gave similar results to those for fraction 29 (not shown).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7260</offset><text>In many cases it has been found that peptides containing the phosphorylation sites of proteins are also substrates for the protein kinase catalysing the phosphorylation of the protein. We therefore synthesized the peptide RRIEEYHQTTEKN, which represents amino acid residues 78-88 of H5R preceded by two arginine residues (not present at positions 76-77 of the protein) to make the peptide easier to handle. As preliminary studies indicated that this served as a substrate for the B1R kinase we had two additional peptides constructed in one of which Ala replaced Thr-84 and in the other of which it replaced Thr-85. After incubation with B1R kinase and [&#947;-32P]ATP the peptides were subjected to high-voltage thin layer electrophoresis to resolve the peptides from the unreacted [&#947;-32P]ATP. Fig 3 shows that although there was some labelling of the two Ala-replacement peptides, this was much less than with the parent peptide. (Measurement indicated that this was about 10% of incorporation into the parent peptide). It would therefore appear that the recognition specificity for phosphorylation at either Thr residue includes the other Thr, despite the fact that in one case it is on the N-terminal side of the phosphorylated residue, and in the other case on the C-terminal side.</text></passage><passage><infon key="file">1471-2091-1-2-1.jpg</infon><infon key="id">F1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>8550</offset><text>HPLC fractionation of V8 peptides from vaccinia virus protein H5R. (a) HPLC fractionation of hydrolysate after passage through a SEP-PAK column using a gradient of 0-50% acetonitrile. The fractions encompassed by the horizontal bar (region 3) were collected for further analysis. (b) Microbore HPLC fractionation of region 3 from (a). A gradient of 15-25% acetonitrile in 0.1% trifluoroacetic acid was used and the fractions encompassed by the horizontal bars (regions I and II) collected for further analysis). (c) Microbore HPLC fractionation of region II from (b). A gradient of 0-50% acetonitrile in 20 mM NaCl (in the absence of trifluoroacetic acid - i.e. at neutral pH) was used and the fractions 28 and 29 collected for sequence analysis). The direction of increasing gradient is from left to right in all three frames; the ultraviolet absorbance trace is labelled as A280, and the radioactivity trace as 32P.</text></passage><passage><infon key="file">1471-2091-1-2-2.jpg</infon><infon key="id">F2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>9468</offset><text>Sequence analysis of H5R phosphopeptide. Fraction 29 from Fig 1c was subjected to automatic Edman degradation, and the 32P radioactivity released at each stage measured. The identity of the phenylthiohydantoin derivative from the first seven cycles was unequivocal and is indicated.</text></passage><passage><infon key="file">1471-2091-1-2-3.jpg</infon><infon key="id">F3</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>9751</offset><text>Phosphorylation of synthetic peptides. Peptides were phosphorylated as described in the Experimental section and subjected to electrophoresis on thin-layer cellulose at pH 3.5. The position of the phosphopeptides is indicated by the arrow, the identification being based on the fact that the ninhydrin-stained material (predominantly unphosphorylated and hence with a greater positive charge) migrated just ahead of this. Lane 1 contained RRIEEYHQTTEKN, lane 2: RRIEEYHQATEKN, lane 3: RRIEEYHQTAEKN, and lane 4; no peptide.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>10275</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>10286</offset><text>We have identified two phosphorylation sites for vaccinia virus protein kinase B1R in viral protein H5R, the first phosphorylation sites to be determined for this protein kinase. Although we have not established whether these same sites are also phosphorylated during viral infection, our work provides important biochemical information on the substrate specificity of the protein kinase. The sequence containing the two phosphorylated threonine residues - EEYHQTTEKNSP - is neither particularly basic or acidic, consistent with the failure of basic or acidic model peptides to serve as substrates for the B1R protein kinase. It is interesting that this does not resemble sequences reported to be phosphorylated by other protein kinases, including those phosphorylated by CK1, the known cellular protein kinase most closely related to the B1R kinase. This latter generally requires a phosphoserine three amino acids to the N-terminal side of the phosphate-acceptor site, although in some artificial substrates a highly acidic N-terminal region can substitute for this. One interesting biochemical question is what residues in the target sequence we have identified are the determinants for the substrate-specificity for the B1R protein kinase. In one approach to this we have examined the sequences of other known substrates for the B1R kinase (ribosomal proteins Sa and S2) but have been unable to identify potential similarities to the H5R phosphopeptide. In this regard it should be mentioned that although the synthetic peptide RRIEEYHQTTEKN did serve as a substrate for the enzyme (Fig. 3), we found its phosphorylation to be weak compared with that produced by other protein kinases on their model peptides (Approximately 0.1 mol phosphate per mol of peptide, compared with 1.8-2.0 mol phosphate per mol H5R protein). Although the additional arginine residues in the peptide complicate the interpretation, it may well be that there are three-dimensional determinants - absent from the synthetic peptide - that contribute to the substrate specificity of the enzyme. There are precedents for this in some other protein kinases.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>12418</offset><text>The vaccinia protein H5R has been shown by isoelectric focusing to exist in at least four differently charged forms, suggesting that there are at least least five different phosphorylation sites on the protein. Consistent with this are the results of experiments (not shown) in which we employed recombinant H5R in which Thr-84 and Thr-85 had been replaced by Ala residues, and found that this still served as a substrate for the B1R protein kinase. It is possible that one or more of these additional sites is present in the HPLC fraction I of Fig 1b, the peptides resolved from which were insufficiently radioactive for sequence analysis. </text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>13060</offset><text>Although this work represents the first identification of phosphorylation sites for the vaccinia B1R kinase, it remains to be established whether these same sites are phosphorylated in vivo, and, if so, with what physiological significance. However it should now be possible to address this question by constructing recombinant virus with amino acid substitutions at the positions of phosphorylation. </text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>13462</offset><text>Remarkable conclusions</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>13474</offset><text>In vitro, Vaccinia virus protein kinase B1R phosphorylates virus H5R at Thr-84 and TH-85 threonine residues in the region.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>13617</offset><text>Could you tell me EEYHQTTEKNSP?</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>13630</offset><text>The peptide that was synthesized from this sequence also served as a substrate. We conclude that this particular sequence is responsible for the substrate specificity of the vaccinia B1R protein kinase, although it is uncertain which amino acid residues are the primary determinants within this structure. However, there are other phosphorylation sites forthe kate on protein H5R that need to be identified.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>14023</offset><text>Materials and Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>14045</offset><text>Preparation and labelling of H5R protein</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>14086</offset><text>The preparation of authentic vaccinia H5R protein and recombinant B1R protein kinase were as previously described. In some experiments a trpE-H5R fusion protein (pATH11-Ag35) was used. For phosphorylation, three identical reactions contained H5R protein (70 pmol), B1R protein kinase (90 &#956;l), Tris-HCl, pH 7.4 (20 mM), magnesium chloride (5 mM), ATP (50 &#956;M), [&#947;-32P]ATP (50 &#956;Ci) and dithiothreitol (2 mM) in a total volume of 500 &#956;l. Incubation was for 30 min at 30&#176; C.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>14564</offset><text>Proteolytic digestion of H5R protein</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>14601</offset><text>The 500 &#956;l reaction mixtures, above, were adjusted to 50 mM Tris-HCl, pH 7.4, and 0.01% reduced Triton X-100 at a final volume of 600 &#956;l. To this was added 0.4 &#956;g V8 protease (Boehringer Mannheim) and incubation carried out at 30&#176; C for 18 h. To prepare the peptides for HPLC analysis the reaction mixtures were pooled and applied to a SEP-PAK cartridge (prewashed with successive 10 ml portions of 50% acetonitrile and water) and eluted with water (40 ml) followed by 50% acetonitrile (40 ml) and finally 100% acetonitrile (30 ml). A large peak of radioactivity (unreacted ATP) eluted with the water and was discarded, and a smaller broad peak of radioactivity that eluted with 50% acetonitrile was retained and concentrated to 200 &#956;l by rotary evaporation.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>15365</offset><text>Purification of H5R peptides and sequence analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>15416</offset><text>Initial purification was with a Vydac protein and Peptide C18 column (25 &#215; 04 cm) on a Gilson HPLC system, and this was followed by further purification on a Vydac C18 2.1 &#215; 180 mm microbore column. Details of the gradients used are given in the text. Peptides were sequenced on an Applied Biosystems 476A protein sequencer and phosphorylation sites were analysed using solid phase Edmann sequencing.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>15819</offset><text>Labelling and analysis of synthetic peptides</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>15864</offset><text>Synthetic peptides were purchased from Thistle Research, Glasgow, UK. Each peptide (3 mM) was incubated with [&#947;-32P]ATP (6.3 &#956;Ci) B1R protein kinase (4 &#956;l), Tris-HCl, pH 7.4 (20 mM), magnesium chloride (5 mM), ATP (50 &#956;M), and dithiothreitol (2 mM) in a total volume of 20 &#956;l. Incubation was for 30 min at 30&#176; C. The reaction mixtures were applied in 1 cm strips to thin layer cellulose plates and subjected to electrophoresis for 4 h at 200 V in a solution of pyridine : acetic acid : water (20:200:1780) at pH 3.5. The plates were dried, stained with ninhydrin to locate the unphosphorylated peptides, and subjected to autoradiography.</text></passage><passage><infon key="fpage">2637</infon><infon key="lpage">2671</infon><infon key="name_0">surname:Moss;given-names:B</infon><infon key="section_type">REF</infon><infon key="source">In Fields Virology, 3rd edn (Edited by Field BN, Knipe DM, Howley, PM) Philadelphia: Lippincott-Raven,</infon><infon key="type">ref</infon><infon key="year">1996</infon><offset>16510</offset><text>Poxviridae: the viruses and their replication.</text></passage><passage><infon key="fpage">4413</infon><infon key="lpage">4426</infon><infon key="name_0">surname:Rempel;given-names:RE</infon><infon key="name_1">surname:Traktman;given-names:P</infon><infon key="pub-id_pmid">1602551</infon><infon key="section_type">REF</infon><infon key="source">J Virol</infon><infon key="type">ref</infon><infon key="volume">66</infon><infon key="year">1992</infon><offset>16557</offset><text>Vaccinia virus B1 kinase: phenotypic analysis of temperature-sensitive mutants and enzymatic characterization of recombinant proteins.</text></passage><passage><infon key="fpage">2717</infon><infon key="lpage">2723</infon><infon key="name_0">surname:Lin;given-names:SQ</infon><infon key="name_1">surname:Wen;given-names:C</infon><infon key="name_2">surname:Broyles;given-names:SS</infon><infon key="pub-id_pmid">1560522</infon><infon key="section_type">REF</infon><infon key="source">J Virol</infon><infon key="type">ref</infon><infon key="volume">66</infon><infon key="year">1992</infon><offset>16692</offset><text>The vaccinia virus B1R gene product is a serine/threonine protein kinase.</text></passage><passage><infon key="fpage">7653</infon><infon key="lpage">7657</infon><infon key="name_0">surname:Lin;given-names:S</infon><infon key="name_1">surname:Broyles;given-names:SS</infon><infon key="pub-id_pmid">8052637</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci U S A</infon><infon key="type">ref</infon><infon key="volume">91</infon><infon key="year">1994</infon><offset>16766</offset><text>Vaccinia protein kinase 2: a second essential serine/threonine protein kinase encoded by vaccinia virus.</text></passage><passage><infon key="fpage">6581</infon><infon key="lpage">6587</infon><infon key="name_0">surname:Traktman;given-names:P</infon><infon key="name_1">surname:Caligiuri;given-names:A</infon><infon key="name_2">surname:Jesty;given-names:SA</infon><infon key="name_3">surname:Liu;given-names:K</infon><infon key="name_4">surname:Sankar;given-names:U</infon><infon key="pub-id_pmid">7666563</infon><infon key="section_type">REF</infon><infon key="source">J Virol</infon><infon key="type">ref</infon><infon key="volume">69</infon><infon key="year">1995</infon><offset>16871</offset><text>Temperature-sensitive mutants with lesions in the vaccinia virus F10 kinase undergo arrest at the earliest stage of virion morphogenesis.</text></passage><passage><infon key="fpage">6376</infon><infon key="lpage">88</infon><infon key="name_0">surname:Wang;given-names:S</infon><infon key="name_1">surname:Shuman;given-names:S</infon><infon key="pub-id_pmid">7666539</infon><infon key="section_type">REF</infon><infon key="source"> J Virol</infon><infon key="type">ref</infon><infon key="volume">69</infon><infon key="year">1995</infon><offset>17009</offset><text>Vaccinia virus morphogenesis is blocked by temperature-sensitive mutations in the F10 gene, which encodes protein kinase 2.</text></passage><passage><infon key="fpage">803</infon><infon key="lpage">812</infon><infon key="name_0">surname:Banham;given-names:AH</infon><infon key="name_1">surname:Smith;given-names:GL</infon><infon key="pub-id_pmid">1448924</infon><infon key="section_type">REF</infon><infon key="source">Virology</infon><infon key="type">ref</infon><infon key="volume">191</infon><infon key="year">1992</infon><offset>17133</offset><text>Vaccinia virus gene B1R encodes a 34-kDa serine/threonine protein kinase that localizes in cytoplasmic factories and is packaged into virions.</text></passage><passage><infon key="fpage">574</infon><infon key="lpage">583</infon><infon key="name_0">surname:Rempel;given-names:RE</infon><infon key="name_1">surname:Anderson;given-names:MK</infon><infon key="name_2">surname:Evans;given-names:E</infon><infon key="name_3">surname:Traktman;given-names:P</infon><infon key="pub-id_pmid">2296077</infon><infon key="section_type">REF</infon><infon key="source">J Virol</infon><infon key="type">ref</infon><infon key="volume">64</infon><infon key="year">1990</infon><offset>17276</offset><text>Temperature-sensitive vaccinia virus mutants identify a gene with an essential role in viral replication.</text></passage><passage><infon key="fpage">27</infon><infon key="lpage">31</infon><infon key="name_0">surname:Banham;given-names:AH</infon><infon key="name_1">surname:Leader;given-names:DP</infon><infon key="name_2">surname:Smith;given-names:GL</infon><infon key="pub-id_doi">10.1016/0014-5793(93)80614-Z</infon><infon key="pub-id_pmid">8467908</infon><infon key="section_type">REF</infon><infon key="source">FEBS Lett</infon><infon key="type">ref</infon><infon key="volume">321</infon><infon key="year">1993</infon><offset>17382</offset><text>Phosphorylation of ribosomal proteins by the vaccinia virus B1R protein kinase.</text></passage><passage><infon key="fpage">283</infon><infon key="lpage">293</infon><infon key="name_0">surname:Beaud;given-names:G</infon><infon key="name_1">surname:Sharif;given-names:A</infon><infon key="name_2">surname:Topa-Masse;given-names:A</infon><infon key="name_3">surname:Leader;given-names:DP</infon><infon key="pub-id_pmid">8113749</infon><infon key="section_type">REF</infon><infon key="source">J Gen Virol</infon><infon key="type">ref</infon><infon key="volume">75</infon><infon key="year">1994</infon><offset>17462</offset><text>Ribosomal protein S2/Sa kinase purified from HeLa cells infected with vaccinia virus corresponds to the B1R protein kinase and phosphorylates in vitro the viral ssDNA-binding protein.</text></passage><passage><infon key="fpage">1819</infon><infon key="lpage">1826</infon><infon key="name_0">surname:Beaud;given-names:G</infon><infon key="name_1">surname:Beaud;given-names:R</infon><infon key="name_2">surname:Leader;given-names:DP</infon><infon key="pub-id_pmid">7853522</infon><infon key="section_type">REF</infon><infon key="source">J Virol</infon><infon key="type">ref</infon><infon key="volume">69</infon><infon key="year">1995</infon><offset>17646</offset><text>Vaccinia virus gene H5R encodes a protein that is phosphorylated by the multisubstrate vaccinia virus B1R protein kinase.</text></passage><passage><infon key="fpage">67</infon><infon key="lpage">70</infon><infon key="name_0">surname:Beaud;given-names:G</infon><infon key="name_1">surname:Beaud;given-names:R</infon><infon key="pub-id_doi">10.1159/000025025</infon><infon key="pub-id_pmid">10773740</infon><infon key="section_type">REF</infon><infon key="source">Intervirology</infon><infon key="type">ref</infon><infon key="volume">43</infon><infon key="year">2000</infon><offset>17768</offset><text>Temperature-dependent phosphorylation state of the H5R protein synthesised at the early stage of infection in cells infected with vaccinia virus ts mutants of the B1R and F10L protein kinases.</text></passage><passage><infon key="fpage">3297</infon><infon key="lpage">3302</infon><infon key="name_0">surname:Beaud;given-names:G</infon><infon key="name_1">surname:Beaud;given-names:R</infon><infon key="pub-id_pmid">9400980</infon><infon key="section_type">REF</infon><infon key="source">J Gen Virol</infon><infon key="type">ref</infon><infon key="volume">78</infon><infon key="year">1997</infon><offset>17961</offset><text>Preferential virosomal location of underphosphorylated H5R protein synthesized in vaccinia virus-infected cells.</text></passage><passage><infon key="fpage">6796</infon><infon key="lpage">6802</infon><infon key="name_0">surname:Kovacs;given-names:GR</infon><infon key="name_1">surname:Moss;given-names:B</infon><infon key="pub-id_pmid">8794318</infon><infon key="section_type">REF</infon><infon key="source">J Virol</infon><infon key="type">ref</infon><infon key="volume">70</infon><infon key="year">1996</infon><offset>18074</offset><text>The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression.</text></passage><passage><infon key="fpage">313</infon><infon key="lpage">322</infon><infon key="name_0">surname:Black;given-names:EP</infon><infon key="name_1">surname:Moussache;given-names:N</infon><infon key="name_2">surname:Condit;given-names:RC</infon><infon key="pub-id_doi">10.1006/viro.1998.9166</infon><infon key="pub-id_pmid">9636370</infon><infon key="section_type">REF</infon><infon key="source">Virology</infon><infon key="type">ref</infon><infon key="volume">245</infon><infon key="year">1998</infon><offset>18187</offset><text>Characterization of the interactions among vaccinia virus transcription factors G2R, A18R, and H5R. </text></passage><passage><infon key="fpage">2393</infon><infon key="lpage">2405</infon><infon key="name_0">surname:DeMasi;given-names:J</infon><infon key="name_1">surname:Traktman;given-names:P</infon><infon key="pub-id_doi">10.1128/JVI.74.5.2393-2405.2000</infon><infon key="pub-id_pmid">10666270</infon><infon key="section_type">REF</infon><infon key="source"> J Virol</infon><infon key="type">ref</infon><infon key="volume">74</infon><infon key="year">2000</infon><offset>18288</offset><text>Clustered charge-to-alanine mutagenesis of the vaccina virus H5 gene: isolation of a dominant temperature-sensitive mutant with a profound defect in morphogenesis.</text></passage><passage><infon key="fpage">247</infon><infon key="lpage">266</infon><infon key="name_0">surname:Goebel;given-names:SJ</infon><infon key="name_1">surname:Johnson;given-names:GP</infon><infon key="name_2">surname:Perkus;given-names:ME</infon><infon key="name_3">surname:Davis;given-names:SW</infon><infon key="name_4">surname:Winslow;given-names:JP</infon><infon key="name_5">surname:Paoletti;given-names:E</infon><infon key="pub-id_pmid">2219722</infon><infon key="section_type">REF</infon><infon key="source">Virology</infon><infon key="type">ref</infon><infon key="volume">179</infon><infon key="year">1990</infon><offset>18452</offset><text>The complete sequence of vaccinia virus.</text></passage><passage><infon key="fpage">191</infon><infon key="lpage">225</infon><infon key="name_0">surname:Pinna;given-names:LA</infon><infon key="name_1">surname:Ruzzene;given-names:M</infon><infon key="pub-id_doi">10.1016/S0167-4889(96)00083-3</infon><infon key="pub-id_pmid">8982275</infon><infon key="section_type">REF</infon><infon key="source">Biochim Biophys Acta</infon><infon key="type">ref</infon><infon key="volume">1314</infon><infon key="year">1996</infon><offset>18493</offset><text>How do protein kinases recognize their substrates?</text></passage><passage><infon key="fpage">207</infon><infon key="lpage">219</infon><infon key="name_0">surname:Mohandas;given-names:AR</infon><infon key="name_1">surname:Dekaban;given-names:GA</infon><infon key="name_2">surname:Dales;given-names:S</infon><infon key="pub-id_doi">10.1006/viro.1994.1179</infon><infon key="pub-id_pmid">8128622</infon><infon key="section_type">REF</infon><infon key="source">Virology</infon><infon key="type">ref</infon><infon key="volume">200</infon><infon key="year">1994</infon><offset>18544</offset><text>Vaccinia virion surface polypeptide Ag35 expressed from a baculovirus vector is targeted to analogous poxvirus and insect virus components</text></passage><passage><infon key="fpage">5920</infon><infon key="lpage">5930</infon><infon key="name_0">surname:Ben-Levy;given-names:R</infon><infon key="name_1">surname:Leishton;given-names:IA</infon><infon key="name_2">surname:Doza;given-names:YN</infon><infon key="name_3">surname:Attwood;given-names:P</infon><infon key="name_4">surname:Morrice;given-names:N</infon><infon key="name_5">surname:Marshall;given-names:CJ</infon><infon key="name_6">surname:Cohen;given-names:P</infon><infon key="pub-id_pmid">8846784</infon><infon key="section_type">REF</infon><infon key="source">EMBO J</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">1995</infon><offset>18683</offset><text>Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2</text></passage></document></collection>